Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.
2.

Is it time to revise the normal range of serum uric acid levels?

Desideri G, Castaldo G, Lombardi A, Mussap M, Testa A, Pontremoli R, Punzi L, Borghi C.

Eur Rev Med Pharmacol Sci. 2014;18(9):1295-306. Review.

3.

[Is hyperuricemia a cardiovascular risk factor?].

Chizyński K, Rózycka M.

Wiad Lek. 2006;59(5-6):364-7. Review. Polish.

PMID:
17017483
4.

Cardiovascular and renal effects of hyperuricaemia and gout.

Viazzi F, Leoncini G, Pontremoli R.

Reumatismo. 2012 Jan 19;63(4):253-62. doi: 10.4081/reumatismo.2011.253. Review.

PMID:
22303532
5.

Systematic review of the prevalence of gout and hyperuricaemia in Australia.

Robinson PC, Taylor WJ, Merriman TR.

Intern Med J. 2012 Sep;42(9):997-1007. doi: 10.1111/j.1445-5994.2012.02794.x. Epub 2012 Apr 4. Review.

PMID:
24020339
6.

The kidney in hyperuricemia and gout.

Mount DB.

Curr Opin Nephrol Hypertens. 2013 Mar;22(2):216-23. doi: 10.1097/MNH.0b013e32835ddad2. Review.

PMID:
23318701
7.

Epidemiology of gout.

Roddy E, Choi HK.

Rheum Dis Clin North Am. 2014 May;40(2):155-75. doi: 10.1016/j.rdc.2014.01.001. Epub 2014 Feb 19. Review.

8.

Gout and hyperuricemia.

Harris MD, Siegel LB, Alloway JA.

Am Fam Physician. 1999 Feb 15;59(4):925-34. Review.

9.

The interplay between diet, urate transporters and the risk for gout and hyperuricemia: current and future directions.

Torralba KD, De Jesus E, Rachabattula S.

Int J Rheum Dis. 2012 Dec;15(6):499-506. doi: 10.1111/1756-185X.12010. Epub 2012 Oct 22. Review.

PMID:
23253231
10.

Research progress in the genetics of hyperuricaemia and gout.

Min Z, Junwu M.

Yi Chuan. 2016 Apr;38(4):300-13. doi: 10.16288/j.yczz.15-385. Review.

PMID:
27103454
11.

Hypertension, its treatment, hyperuricaemia and gout.

Gibson TJ.

Curr Opin Rheumatol. 2013 Mar;25(2):217-22. doi: 10.1097/BOR.0b013e32835cedd4. Review.

PMID:
23370375
12.

Clinical manifestations of hyperuricemia and gout.

Mandell BF.

Cleve Clin J Med. 2008 Jul;75 Suppl 5:S5-8. Review.

PMID:
18822469
13.

Safety of urate-lowering therapies: managing the risks to gain the benefits.

Keenan RT.

Rheum Dis Clin North Am. 2012 Nov;38(4):663-80. doi: 10.1016/j.rdc.2012.08.008. Epub 2012 Sep 7. Review.

PMID:
23137576
14.

[Hyperuricemia, gout and cardiovascular diseases].

Murray K, Burkard T.

Ther Umsch. 2016;73(3):141-6. doi: 10.1024/0040-5930/a000770. Review. German.

PMID:
27008446
15.

Clinical features of gout.

Grassi W, De Angelis R.

Reumatismo. 2012 Jan 19;63(4):238-45. doi: 10.4081/reumatismo.2011.238. Review.

PMID:
22303530
16.

Medical implications of hyperuricemia.

Sachs L, Batra KL, Zimmermann B.

Med Health R I. 2009 Nov;92(11):353-5. Review. No abstract available.

PMID:
19999892
17.

Gout and hyperuricemia in young people.

Yamanaka H.

Curr Opin Rheumatol. 2011 Mar;23(2):156-60. doi: 10.1097/BOR.0b013e3283432d35. Review.

PMID:
21169841
18.

[Gout and comorbidities associated with hyperuricemia].

Majdan M, Borys O.

Ann Acad Med Stetin. 2010;56 Suppl 1:34-9. Review. Polish.

PMID:
21365938
19.

[Hyperuricemia - more than gout : Impact on cardiovascular risk and renal insufficiency].

Sellin L, Kielstein JT, de Groot K.

Z Rheumatol. 2015 May;74(4):322-8. doi: 10.1007/s00393-014-1481-1. Review. German.

PMID:
25962453
20.

Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease.

Johnson RJ, Kivlighn SD, Kim YG, Suga S, Fogo AB.

Am J Kidney Dis. 1999 Feb;33(2):225-34. Review.

PMID:
10023633

Supplemental Content

Support Center